Search
Markets
News
Analysis
Tools
Stock Screener
Learn
Scan to Download
One powerful score. Smarter investment decisions.
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
Log in
Start for free
Search
Start for free
Markets
/
Stocks
/
nasdaq-iova
/
Iovance Biotherapeutics Inc
IOVA
Add to Watchlist
3.970
USD
-0.190
-4.57%
Close 07/01, 16:00(ET)
Quotes delayed by 15 min
0.000
USD
0.000
Pre-market 07/02, 09:30 (ET)
1.77B
Market Cap
Loss
P/E TTM
Iovance Biotherapeutics Inc
3.970
-0.190
-4.57%
Overview
Financials
Discussions
Analysis
Company
Profile
Revenue
Shareholders
Corporate
Overview
Financials
Discussions
Analysis
Company
Profile
Revenue
Shareholders
Corporate
Shareholding Stats
Updated: Sun, May 10
Updated: Sun, May 10
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
MHR Fund Management LLC
6.49%
Quogue Capital L.L.C.
6.29%
BlackRock Institutional Trust Company, N.A.
5.45%
State Street Investment Management (US)
3.91%
Vanguard Capital Management, LLC
3.72%
Other
74.15%
Shareholders
Shareholders
Proportion
MHR Fund Management LLC
6.49%
Quogue Capital L.L.C.
6.29%
BlackRock Institutional Trust Company, N.A.
5.45%
State Street Investment Management (US)
3.91%
Vanguard Capital Management, LLC
3.72%
Other
74.15%
Shareholder Types
Shareholders
Proportion
Investment Advisor
22.29%
Hedge Fund
12.72%
Investment Advisor/Hedge Fund
10.70%
Research Firm
8.50%
Private Equity
6.52%
Venture Capital
6.40%
Individual Investor
0.32%
Pension Fund
0.32%
Bank and Trust
0.30%
Other
31.92%
Institutional Shareholding
Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
655
299.13M
69.13%
+3.21M
2025Q4
659
246.02M
61.97%
-76.61M
2025Q3
650
248.97M
62.75%
-52.51M
2025Q2
654
271.34M
81.00%
-28.55M
2025Q1
680
275.16M
84.08%
-27.55M
2024Q4
654
278.66M
85.07%
-21.74M
2024Q3
641
272.75M
89.13%
-24.76M
2024Q2
630
269.09M
94.68%
-12.01M
2024Q1
622
253.92M
89.61%
-22.91M
2023Q4
605
240.15M
93.91%
-35.32M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
MHR Fund Management LLC
28.97M
7.03%
--
--
Dec 31, 2025
Quogue Capital L.L.C.
28.07M
6.81%
--
--
Apr 17, 2025
BlackRock Institutional Trust Company, N.A.
24.34M
5.91%
+2.66M
+12.25%
Dec 31, 2025
State Street Investment Management (US)
20.16M
4.89%
+6.85M
+51.48%
Dec 31, 2025
BofA Global Research (US)
14.28M
3.47%
+8.00M
+127.38%
Dec 31, 2025
Invenomic Capital Management LP
11.96M
2.9%
+1.42M
+13.45%
Dec 31, 2025
Morgan Stanley & Co. LLC
8.80M
2.14%
+3.70M
+72.57%
Dec 31, 2025
Long Focus Capital Management LLC
8.60M
2.09%
-516.51K
-5.67%
Dec 31, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
Virtus LifeSci Biotech Products ETF
1.36%
iShares Genomics Immunology and Healthcare ETF
1.14%
WisdomTree BioRevolution Fund
0.51%
Invesco NASDAQ Future Gen 200 ETF
0.47%
State Street SPDR S&P Biotech ETF
0.23%
Direxion Daily S&P Biotech Bull 3X Shares
0.14%
ProShares Ultra Nasdaq Biotechnology
0.11%
Invesco Nasdaq Biotechnology ETF
0.07%
Invesco RAFI US 1500 Small-Mid ETF
0.07%
iShares Biotechnology ETF
0.05%
View more
Virtus LifeSci Biotech Products ETF
Proportion
1.36%
iShares Genomics Immunology and Healthcare ETF
Proportion
1.14%
WisdomTree BioRevolution Fund
Proportion
0.51%
Invesco NASDAQ Future Gen 200 ETF
Proportion
0.47%
State Street SPDR S&P Biotech ETF
Proportion
0.23%
Direxion Daily S&P Biotech Bull 3X Shares
Proportion
0.14%
ProShares Ultra Nasdaq Biotechnology
Proportion
0.11%
Invesco Nasdaq Biotechnology ETF
Proportion
0.07%
Invesco RAFI US 1500 Small-Mid ETF
Proportion
0.07%
iShares Biotechnology ETF
Proportion
0.05%